Q7TQI0
Gene name |
Tmem204 (Clp24) |
Protein name |
Transmembrane protein 204 |
Names |
Claudin-like protein 24 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:407831 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q7TQI0
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q7TQI0-F1 | Predicted | AlphaFoldDB |
18 variants for Q7TQI0
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3389444741 | 15 | L>M | No | EVA | |
| rs3389451585 | 26 | F>V | No | EVA | |
| rs3389436591 | 32 | Y>N | No | EVA | |
| rs3389444744 | 42 | S>* | No | EVA | |
| rs3389457927 | 44 | G>E | No | EVA | |
| rs3389449856 | 45 | L>V | No | EVA | |
| rs3389409629 | 46 | W>G | No | EVA | |
| rs3389451617 | 59 | T>A | No | EVA | |
| rs3407499536 | 67 | Q>* | No | EVA | |
| rs3389457968 | 118 | I>N | No | EVA | |
| rs108349389 | 128 | S>P | No | EVA | |
| rs3407356621 | 133 | C>R | No | EVA | |
| rs3407563628 | 133 | C>Y | No | EVA | |
| rs3389440760 | 186 | L>H | No | EVA | |
| rs3389391235 | 196 | D>G | No | EVA | |
| rs3389421429 | 200 | P>T | No | EVA | |
| rs3389403490 | 205 | I>V | No | EVA | |
| rs3389432938 | 221 | Y>* | No | EVA |
No associated diseases with Q7TQI0
No regional properties for Q7TQI0
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q7TQI0 | |||
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| adherens junction | A cell-cell junction composed of the epithelial cadherin-catenin complex. The epithelial cadherins, or E-cadherins, of each interacting cell extend through the plasma membrane into the extracellular space and bind to each other. The E-cadherins bind to catenins on the cytoplasmic side of the membrane, where the E-cadherin-catenin complex binds to cytoskeletal components and regulatory and signaling molecules. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| lymph vessel development | The process whose specific outcome is the progression of a lymph vessel over time, from its formation to the mature structure. |
| regulation of vascular endothelial growth factor receptor signaling pathway | Any process that modulates the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity. |
| smooth muscle cell differentiation | The process in which a relatively unspecialized cell acquires specialized features of a smooth muscle cell; smooth muscle lacks transverse striations in its constituent fibers and are almost always involuntary. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MTLQKLVATA | VLVALVSLIL | NNAAAFTPNW | VYQTLEDGRK | RSVGLWKSCW | LVDRGKGVTS |
| 70 | 80 | 90 | 100 | 110 | 120 |
| PGTRTGQVDT | HDCEVLGWGS | ESAGFQESRG | TVKLQFDMMR | ACNLVATAAL | VVGQITFILG |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LTGLPLMSPE | SQCWEEAMAA | AFQLASFVLV | IGLVTFYRIG | PYTNLSWSCY | LNIGACLLAT |
| 190 | 200 | 210 | 220 | ||
| LAAAMLIWNI | LHRREDCMAP | RVIVISRSLT | ARFRRGLDND | YVESPC |